(Expiration date: May 8, 2013)
Keyvan Farahani, Ph.D.
The NCI encourages innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This initiative will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first-in-human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this initiative.